Impax Asset Management Group plc Decreases Stake in Mettler-Toledo International, Inc. $MTD

Impax Asset Management Group plc cut its holdings in shares of Mettler-Toledo International, Inc. (NYSE:MTD) by 10.5% during the 2nd quarter, HoldingsChannel reports. The institutional investor owned 171,431 shares of the medical instruments supplier’s stock after selling 20,036 shares during the quarter. Mettler-Toledo International comprises approximately 1.2% of Impax Asset Management Group plc’s portfolio, making the stock its 24th largest holding. Impax Asset Management Group plc’s holdings in Mettler-Toledo International were worth $201,383,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also bought and sold shares of MTD. WPG Advisers LLC purchased a new position in shares of Mettler-Toledo International during the first quarter valued at approximately $41,000. NewSquare Capital LLC grew its position in Mettler-Toledo International by 94.4% in the 2nd quarter. NewSquare Capital LLC now owns 35 shares of the medical instruments supplier’s stock worth $41,000 after purchasing an additional 17 shares during the period. Zions Bancorporation National Association UT purchased a new stake in Mettler-Toledo International during the 1st quarter valued at $43,000. Sound Income Strategies LLC lifted its holdings in shares of Mettler-Toledo International by 477.8% during the 2nd quarter. Sound Income Strategies LLC now owns 52 shares of the medical instruments supplier’s stock valued at $61,000 after buying an additional 43 shares during the period. Finally, Caitong International Asset Management Co. Ltd purchased a new position in shares of Mettler-Toledo International in the 2nd quarter worth $63,000. Hedge funds and other institutional investors own 95.07% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on MTD. Bank of America upped their price objective on Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the company a “neutral” rating in a research report on Monday, September 22nd. Barclays increased their price objective on shares of Mettler-Toledo International from $1,350.00 to $1,600.00 and gave the stock an “overweight” rating in a research note on Monday. Citigroup raised their price objective on shares of Mettler-Toledo International from $1,600.00 to $1,700.00 and gave the stock a “buy” rating in a report on Monday. Wells Fargo & Company upped their target price on shares of Mettler-Toledo International from $1,200.00 to $1,400.00 and gave the company an “equal weight” rating in a report on Monday. Finally, JPMorgan Chase & Co. lifted their price target on shares of Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the stock a “neutral” rating in a research note on Thursday, October 9th. Five analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $1,406.50.

Mettler-Toledo International Stock Up 0.3%

NYSE MTD opened at $1,448.86 on Thursday. Mettler-Toledo International, Inc. has a twelve month low of $946.69 and a twelve month high of $1,471.07. The business has a 50-day moving average price of $1,330.14 and a 200-day moving average price of $1,244.83. The firm has a market cap of $29.85 billion, a price-to-earnings ratio of 36.69, a price-to-earnings-growth ratio of 4.19 and a beta of 1.41.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings results on Thursday, November 6th. The medical instruments supplier reported $11.15 EPS for the quarter, topping analysts’ consensus estimates of $10.62 by $0.53. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The company had revenue of $1.03 billion for the quarter, compared to analysts’ expectations of $997.36 million. During the same period in the previous year, the firm earned $10.21 EPS. The firm’s revenue was up 7.9% compared to the same quarter last year. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS. FY 2025 guidance at 42.050-42.250 EPS. Research analysts expect that Mettler-Toledo International, Inc. will post 42.71 EPS for the current fiscal year.

Insider Buying and Selling at Mettler-Toledo International

In related news, CFO Shawn Vadala sold 300 shares of the firm’s stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $1,325.00, for a total transaction of $397,500.00. Following the completion of the transaction, the chief financial officer directly owned 5,095 shares of the company’s stock, valued at approximately $6,750,875. This trade represents a 5.56% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Corporate insiders own 1.94% of the company’s stock.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.